Stem cells reverse symptoms of multiple sclerosis, study finds

01/29/2009 | Yahoo!

A U.S. study involving 21 people with relapsing-remitting multiple sclerosis -- an earlier phase in the disease -- reported that about 81% showed improvement after their immune systems were reset through an injection of stem cells derived from their own bone marrow. Called autologous nonmyeloablative hematopoietic stem cell transplantation, the treatment is less toxic than the chemotherapy treatment used in cancer patients because it targets only the immune system component of bone marrow, one of the scientists said.

View Full Article in:

Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC